share_log

Guggenheim Reiterates Neutral on Spruce Biosciencesto Neutral

Benzinga ·  Dec 12 23:38

Guggenheim analyst Evan Wang reiterates Spruce Biosciences (NASDAQ:SPRB) from Neutral to Neutral.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment